New licence agreement between Queen’s University and Taysha Gene Therapies could lead to development of treatments for rare diseases in children
FOR IMMEDIATE RELEASE
Monday, Sept. 28, 2020
KINGSTON, Ont. – Queen’s University announced that it has entered into a research collaboration and licensing agreement with Taysha Gene Therapies, Inc., for the development and commercialization of gene therapy for GM2 gangliosidoses.
The GM2 gangliosidoses are a group of degenerative/inflammatory diseases...Read more
In September 1845, a notice started appearing in the Kingston Chronicle and Gazette stating that “The Hotel Dieu” on Brock Street was now open “for the reception of persons requiring Medical or Surgical assistance” with a single daily visiting hour from 9 to 10 a.m.